Gonadotropins Regulate Inducible Cyclic Adenosine 3',5'-Monophosphate Early Repressor in the Rat Ovary: Implications for Inhibin
Subunit Gene Expression
Abir Mukherjee,
Janice Urban,
Paolo Sassone-Corsi and
Kelly E. Mayo
Department of Biochemistry, Molecular Biology, and Cell Biology
(A.M., K.E.M.) Northwestern University Evanston, Illinois
60208
Department of Physiology and Biophysics (J.U.)
Chicago Medical School North Chicago, Illinois 60064
Institut de Genetique et de Biologie Moleculaire et
Cellulaire (P.S.-C.) Centre National de la Recherche
Scientifique-INSERM-ULP BP163, 67404 Ilkirch, Strasbourg,
France
 |
ABSTRACT
|
---|
Many hormones that stimulate intracellular
signaling pathways utilizing the second messenger cAMP affect gene
expression in target cells through the activation of cAMP-responsive
transcriptional regulatory proteins. Two of the best characterized of
these are the cAMP-response element (CRE)-binding protein (CREB) and
the CRE-modulatory protein (CREM). CREB and CREM are expressed as a
family of proteins that have diverse activities in either stimulating
or repressing gene transcription. In this study we examined the
expression and regulation of the CREM gene in the rat ovary and in
granulosa cells, to determine whether repressor isoforms of CREM might
have a role in the LH-mediated suppression of inhibin
-subunit gene
expression that occurs just before ovulation. We found that the
predominant CREM mRNAs in the ovary correspond to previously described
internal transcripts of the CREM gene that encode the inducible cAMP
early repressor (ICER). ICER mRNAs are strongly induced in the ovary by
exogenous gonadotropins in immature rats and are transiently expressed
in the ovary immediately after the preovulatory LH surge in adult
cycling rats. Although ICER is expressed in multiple ovarian cell
types, expression in granulosa cells is observed only in response to LH
stimulation. ICER mRNAs are also induced by the activation of
cAMP-signaling pathways in cultured primary granulosa cells. To
determine whether ICER can act as a functional repressor to modulate
potential target genes such as the inhibin
-subunit gene, an ICER
expression construct was transiently cotransfected into a granulosa
cell line along with an inhibin
-subunit promoter-luciferase
reporter gene. Both basal and cAMP-induced expression of the inhibin
-subunit promoter were suppressed by ICER. These studies reveal that
CREM, a tissue-specific factor, is expressed and regulated by
gonadotropins in the ovary, that the predominant CREM transcripts
encode the repressor protein ICER, and that ICER is capable of
inhibiting cAMP-induced expression of the inhibin
-subunit gene. Our
findings are consistent with a role for repressors such as ICER in
mediating the suppression of inhibin
-subunit gene expression that
occurs in the ovary at the time of the preovulatory LH surge.
 |
INTRODUCTION
|
---|
During the rodent estrous cycle, FSH secreted from the pituitary
stimulates the growth and maturation of ovarian follicles, and this is
accompanied by increased expression of many FSH-responsive genes within
the granulosa cells of the growing follicle. One such target gene
encodes the
-subunit of inhibin, a dimeric gonadal hormone that, in
turn, acts to suppress the synthesis and secretion of pituitary FSH
(1). Another FSH target gene is that encoding the LH receptor (2, 3),
and once the mature ovarian follicle acquires functional LH receptors,
the preovulatory LH surge on proestrus afternoon triggers the
morphological and biochemical changes associated with ovulation of the
oocyte and luteinization of the remaining follicle cells. In response
to the LH surge, the inhibin
-subunit gene is rapidly
down-regulated, leading to decreased inhibin secretion and providing an
environment permissive to the prolonged elevation (the secondary surge)
of FSH secretion that occurs on estrus morning and is critical for the
recruitment of a new cohort of ovarian follicles (for reviews see Refs.
1, 4, and 5).
This basic pattern of FSH stimulation and LH repression during the
estrous cycle is common to a number of genes expressed in the ovary,
including aromatase (6), the LH receptor (2), the FSH receptor (7), and
the inhibin
- and ß-subunits (8). Other genes are similarly
induced by FSH in ovarian granulosa cells, but their expression remains
elevated after the LH surge and during the process of luteinization
(9). Thus, determining the molecular mechanisms through which
gonadotropins exert these effects on gene expression is important for
understanding the normal control of the ovarian cycle and promises to
lend insight into disruptions of this control that might be associated
with reproductive dysfunction, such as infertility.
The gonadotropins FSH and LH act through stimulatory G protein-coupled
receptors expressed on target cells (10, 11) and transduce their
signal, at least in part, by the activation of adenylyl cyclase and the
production of the second messenger cAMP (12, 13). Recent findings
suggest that the gonadotropins can also act through signaling pathways
that lead to the activation of protein kinase C (14, 15) or
intracellular tyrosine kinases (16). While it is not known how FSH and
LH might differentially regulate gene expression, the number of LH
receptors far exceeds the number of FSH receptors on the granulosa
cells of preovulatory follicles (17), and the levels of intracellular
cAMP generated by FSH in small antral follicles are much lower than
those generated by LH in preovulatory follicles (18, 19, 20), suggesting
that the magnitude of the go-nadotropin-induced cAMP signal might
regulate the resultant transcriptional responses.
Many of the transcriptional responses to cAMP are thought to be
mediated by a family of cAMP-responsive factors that belong to the
larger superfamily of bZip proteins, so named for the basic region and
leucine zipper motifs that form the DNA binding and dimerization
domains of these proteins (21, 22, 23). Perhaps the best characterized of
these factors are the cAMP-response element (CRE)-binding protein
(CREB) (24, 25, 26) and the CRE-modulatory protein (CREM) (27, 28, 29). These
proteins have a very similar domain structure, and both CREB and CREM
are expressed as a family of isoforms that can act as cAMP-regulated
stimulators or repressors of gene transcription (26, 27, 30, 31, 32). CREB
is thought to be fairly ubiquitously expressed, whereas CREM expression
is tissue-specific and is highly regulated in neuroendocrine tissues
and cell types (27).
Alternative RNA processing leads to the formation of mRNAs that encode
diverse isoforms of the CREB and CREM proteins. The full-length forms
of these proteins, which include a kinase-inducible (phosphorylation)
domain and one or more glutamine-rich domains with transactivation
function, act as transcriptional activators. For example, CREB 341 and
CREB 327 are strong activators of transcription (33, 34), and CREM
can augment CREB-mediated activation of cAMP-responsive genes (30).
Shorter isoforms of these proteins that include the DNA-binding and
dimerization domains but lack the kinase-inducible or transactivation
domains can act as transcriptional repressors. The proteins I-CREB
(35), CREM
, ß,
, and S-CREM (27, 32) are examples of such
repressor isoforms. These repressor proteins might act either by
occupying CRE sites in target gene promoters as transcriptionally
inactive homodimers or by forming inactive heterodimers with CREB or
other transcriptional activators (32, 36, 37, 38). One of the best
characterized of these repressor isoforms, and the focus of this study,
is the inducible cAMP early repressor (ICER) (39, 40). The ICER mRNA is
transcribed from an intronic promoter of the CREM gene and encodes a
protein that includes DNA-binding and dimerization domains but lacks
the kinase-inducible and transactivation domains, and thus acts as a
potent repressor. The intronic promoter that regulates ICER expression
is itself cAMP responsive, and ICER therefore autoregulates its
expression. ICER has been proposed to be a key signal that is
transiently induced to attenuate cAMP-dependent signaling pathways
(39).
We reported previously that the full-length activator isoform of CREB
is expressed in the rat ovary and that the pituitary gonadotropins do
not regulate CREB gene expression but rather stimulate CREB
phosphorylation, leading to its activation (41). We also demonstrated
that CREB is a key mediator of FSH-stimulated inhibin
-subunit gene
expression in the ovarian granulosa cell (42). Given the increasing
evidence for modulatory effects of CREM isoforms on CREB-mediated gene
transcription, we wanted to test the hypothesis that CREM isoforms play
a role in attenuating the transcriptional response of the inhibin
-subunit gene to gonadotropins and cAMP in ovarian granulosa cells.
In the present study we investigate the expression and regulation of
CREM/ICER mRNA and protein in immature rats treated with exogenous
gonadotropins, in adult rats during the estrous cycle, and in cultured
rat granulosa cells treated with hormones in vitro. We also
test directly the effect of ICER overexpression on inhibin
-subunit
gene promoter activity in a granulosa cell line. Our findings are
consistent with an important role for CREM/ICER in mediating the
repression of the inhibin
- subunit gene that is observed in the
ovary immediately after the preovulatory LH surge.
 |
RESULTS
|
---|
Gonadotropin Regulation of CREM/ICER mRNAs in the Rat Ovary
To determine whether the CREM gene is expressed in the ovary and
is regulated by gonadotropin-induced cAMP signaling pathways, immature
rats were treated with exogenous gonadotropins, and ovarian sections
were analyzed by in situ hybridization using a
[35S]UTP-labeled CREM antisense riboprobe. This probe
corresponds to the full-length
2 form of CREM, as shown
schematically in Fig. 1
. Figure 2
indicates that CREM mRNA is induced in
the ovary within 4 h of PMSG treatment and returns to basal levels
by 48 h after PMSG treatment. In PMSG-primed animals, CREM mRNA is
strongly induced within 1 h of human CG (hCG) treatment and again
returns to basal levels by 12 h after hCG treatment.

View larger version (40K):
[in this window]
[in a new window]
|
Figure 1. CREM and ICER cDNA Clones and Oligonucleotide
Primers
A schematic diagram of the CREM protein is shown at the
top. The boxes represent exons of the
CREM gene. The shaded boxes are coding regions, and the
cross-hatched box corresponds to a region unique to the
ICER isoforms. The two alternative promoters, P1 and P2, and the
alternative initiation codons (ATG) used to generate full-length CREM
isoforms vs. ICER are indicated. Glutamine- rich domains
(Q), the kinase-inducible domain (KID), and two basic-leucine zipper
domains (bZip), each followed by a stop codon (TAA), are shown. The
numbered arrows represent the positions and orientations
of synthetic oligonucleotide primers used in this study.
Below the CREM structure are schematic diagrams of the
cDNA clones or subclones used in this study, including CREM and
2 testis cDNAs, a 5'-CREM subclone prepared from the 2 cDNA, and
cDNAs encoding the four ovarian ICER isoforms.
|
|

View larger version (126K):
[in this window]
[in a new window]
|
Figure 2. Expression and Regulation of CREM mRNA in the
Immature Rat Ovary
The panels within rows include darkfield
photomicrographs of in situ hybridization using a CREM
sense cRNA probe (top row), darkfield photomicrographs
of in situ hybridization using a CREM antisense cRNA
probe (middle row), or brightfield photomicrographs of
the corresponding ovarian sections (bottom row). The
panels within columns include photographs of sections of ovaries from
immature rats that were either untreated or treated with PMSG for 4 or
48 h and subsequently treated with hCG for 1 or 12 h.
|
|
To establish whether the CREM transcripts detected in the ovary
correspond to the full-length forms of CREM or the shorter repressor
forms such as ICER, specific probes were designed to detect these two
mRNA species. A 47- nucleotide antisense oligonucleotide specific to
the unique intronic sequences found in the ICER mRNA was used to detect
ICER, while a CREM
2 5'-probe corresponding to the kinase-inducible
and glutamine-rich domains was used to detect full-length forms of CREM
(all probes are indicated in Fig. 1
). As shown in Fig. 3
, the ICER-specific mRNA expression
pattern in the hormonally treated rat ovary corresponded closely to
that observed previously using the full-length CREM probe. In contrast,
transcripts hybridizing to the 5'-CREM probe were expressed at very low
levels and were not induced by gonadotropins in the immature rat ovary
(Fig. 3
). Thus, inducible CREM expression in the ovary appears to
represent a selective activation of the internal P2 promoter leading to
the generation of ICER mRNAs.

View larger version (60K):
[in this window]
[in a new window]
|
Figure 3. Comparison of 5'-CREM and ICER mRNA Expression in
the Rat Ovary
The panels within rows include darkfield
photomicrographs of in situ hybridization using a
5'-CREM antisense cRNA probe (top row) or darkfield
photomicrographs of in situ hybridization using an ICER
antisense oligonucleotide probe (bottom row). The
panels within columns include photographs of sections of
ovaries from immature rats that were either untreated or treated with
PMSG for 4 or 48 h and subsequently treated with hCG for 1 or
12 h.
|
|
While the gonadotropin-treated immature rat is an excellent and easily
manipulated model for mimicking events that occur during the normal
reproductive cycle in mature animals, we wanted to assess whether ICER
would also be induced in cycling female rats by the normal preovulatory
LH surge. RNA blot analysis was therefore used to detect ICER
transcripts in ovaries isolated from rats at different times during the
4-day estrous cycle. Serum FSH and LH levels were simultaneously
determined in these animals. As shown in Fig. 4A
, ICER transcripts of 1700 and 1900
nucleotides were observed only at 1800 and 2000 h on proestrus.
These times correspond well to the preovulatory LH surge, which began
at 1600 h and peaked at 2000 h on proestrus (Fig. 4B
).
Treatment of the animals with either pentobarbitol or a GnRH antagonist
(WY-45760), which block the preovulatory LH surge (43, 44, 45), also
abolished ICER mRNA induction at 1800 h proestrus (Fig. 4C
). These
data indicate that, in the ovary, ICER is rapidly induced and then
down-regulated in response to the LH surge in animals progressing
through a normal reproductive cycle.

View larger version (52K):
[in this window]
[in a new window]
|
Figure 4. Expression of ICER mRNA in the Rat Ovary during the
Estrous Cycle
Panel A, RNAs (20 µg) isolated from the ovaries of adult rats at the
indicated times during the estrous cycle were examined by Northern RNA
blotting using an ICER-specific oligonucleotide probe. The positions of
the 18S and 28S ribosomal RNA markers are indicated. Panel B, Levels of
FSH and LH in trunk blood from the same group of animals analyzed for
ICER mRNA in panel A were determined by RIA. Error bars
indicate the SEM, n = 3. Panel C, Northern RNA blot
analysis of ICER expression in the ovaries of rats that were treated
with saline or pentobarbitol (Pento) at 1330 h proestrus in one
experiment and with oil or the GnRH antagonist WY-45760 (Antag) at
1200 h proestrus in another experiment. Ovaries were isolated at
1800 h proestrus in both experiments. RNA blots were subsequently
hybridized with a ribosomal protein S2 probe to verify equivalent
loading and transfer of all RNA samples (not shown).
|
|
Cell-Specific Expression of ICER in the Ovary
Although ICER is induced in the immature rat ovary in response to
both PMSG and hCG, we found that the cellular localization of ICER
transcripts was quite distinct after induction by these two
gonadotropins. As shown in Fig. 5
, ICER
mRNA is localized predominantly to thecal and interstitial cells after
PMSG stimulation. In contrast, after hCG stimulation, ICER mRNA is also
localized to the granulosa cells of most large preovulatory follicles.
Interestingly, in all cases, ICER mRNA was found to colocalize with LH
receptor mRNA (Fig. 5
). This suggests that the induction of ICER by
PMSG in thecal and interstitial cells may be mediated by the weak LH
activity of PMSG as opposed to it predominant FSH-like properties
(46).

View larger version (88K):
[in this window]
[in a new window]
|
Figure 5. Cell-Specific Expression of ICER mRNA in the
Gonadotropin-Treated Rat Ovary
Brightfield and darkfield photomicrographs at 100x magnification and
brightfield photomicrographs at 500x magnification of in
situ hybridization using ICER or LH receptor antisense cRNA
probes. The left-hand panels are ovarian sections from
immature rats treated with PMSG for 4 h. The
right-hand panels are ovarian sections from immature
rats treated with PMSG for 48 h followed by hCG for 1 h. In
the high magnification brightfield photographs, theca cells (T),
interstitial cells (I), and granulosa cells (G) are indicated.
|
|
To investigate further this cell type-specific induction of ICER, the
granulosa cell and thecal-interstitial cell compartments were separated
from ovaries of animals treated with exogenous gonadotropins and used
to prepare RNAs that were examined for ICER mRNA expression using an
RT-PCR assay. The PCR primers used in this assay are indicated in Fig. 1
. As shown in Fig. 6
, ICER mRNA is
induced in the thecal and interstitial cell-enriched fraction by both
PMSG and hCG treatment, whereas ICER mRNA is induced in the granulosa
cell-enriched fraction only after hCG treatment. Figure 6
also
indicates that four predominant ICER transcripts were detected by
RT-PCR. Each of these was cloned and sequenced, and this analysis
indicated that they correspond to the four previously characterized
forms of ICER, designated I, I
, II, and II
(39). The exon
structures of these four ICER isoforms are schematically shown in Fig. 1
.

View larger version (27K):
[in this window]
[in a new window]
|
Figure 6. Expression of ICER mRNAs in Granulosa
vs. Thecal-Interstitial Cells
Immature rats were either untreated, treated with PMSG alone, or
treated with PMSG and hCG for various times as indicated. Granulosa
cells were isolated as described in Materials and
Methods, and the remaining ovarian tissue was used as the
thecal and interstitial cell-enriched fraction. Panel A, RT-PCR
products from granulosa cell RNAs. Panel B, RT-PCR products from thecal
and interstitial cell RNAs. The arrows indicate the
positions of the four ICER isoforms I, I , II, and II . Size
markers in nucleotides are shown between the panels. All
RNA samples were also analyzed by RT-PCR for ribosomal protein L19 mRNA
as an internal control (L19).
|
|
Gonadotropin and cAMP Regulation of ICER mRNAs in Granulosa
Cells
To establish whether ICER is expressed and regulated in granulosa
cells maintained in primary culture, granulosa cells were isolated from
the ovaries of immature rats that were either untreated (naive cells)
or were treated with 10 IU of PMSG for 48 h (primed cells). The
cells were treated with gonadotropins or the adenylyl cyclase activator
forskolin for various times, RNA was isolated, and ICER mRNA expression
was monitored using an RT-PCR assay. As shown in Fig. 7
, all four of the ICER transcripts
described in the previous section were detected. These transcripts
could be induced by a high dose of recombinant human FSH in the naive
cells, by a lower dose of hCG in the primed cells, or by the
nonspecific agent forskolin in both cell populations. In the
PMSG-primed cells treated with hCG in vitro, ICER expression
was highly elevated at 1 h, decreased substantially at 4 h,
and returned to basal levels at 12 h after hormone addition (Fig. 7
).

View larger version (28K):
[in this window]
[in a new window]
|
Figure 7. Expression of ICER mRNA in Primary Cultures of Rat
Granulosa Cells
Granulosa cells were isolated either from immature rats (panel A) or
from immature rats treated with PMSG for 24 h (panel B). Cells
were treated with 10 µM forskolin (FSK), 1 IU/ml
recombinant human FSH (RcFSH), or 0.2 IU/ml hCG for the indicated
times. RNAs were analyzed by RT-PCR for ICER mRNAs and autoradiograms
are shown. The arrows indicate the positions of the four
ICER isoforms, I, I , II, and II . Size markers in nucleotides are
shown between the panels. All RNA samples were also
analyzed by RT-PCR for ribosomal protein L19 mRNA as an internal
control (not shown).
|
|
The ability of forskolin to mimic the induction of ICER by
gonadotropins suggests that a cAMP-dependent pathway leading to the
activation of protein kinase A (PKA) is involved. To confirm this, and
to examine the ability of ICER to be induced in an immortalized mouse
granulosa cell line that was used in a subsequent experiment, GRMO2
cells (47, 48) were treated with recombinant FSH or hCG for 1 h in
the presence or absence of H89, an inhibitor of PKA (49). Figure 8
demonstrates that both recombinant FSH
and hCG induce ICER mRNAs in these cells, and this induction is
inhibited by greater than 90% by H89. Thus, ICER mRNAs are rapidly and
transiently induced through a PKA-dependent mechanism in GRMO2
granulosa cells.

View larger version (52K):
[in this window]
[in a new window]
|
Figure 8. Effect of the PKA Inhibitor H89 on ICER mRNA
Induction by Gonadotropins in GRMO2 Cells
Mouse GRMO2 cells were treated in vitro with recombinant
human FSH (RcFSH) or hCG at the indicated doses for 1 h. Cells
treated with the highest doses of RcFSH or hCG were also simultaneously
treated with 10 µM H89, a PKA inhibitor. RNA samples from
these cells were analyzed by RT-PCR for ICER mRNAs. An autoradiogram of
the PCR products is shown. The four arrows indicate the
positions of the four ICER isoforms, I, I , II, and II . All RNA
samples were also analyzed by RT-PCR for ribosomal protein L19 mRNA as
an internal control (not shown).
|
|
ICER Expression and Inhibin
-Subunit Gene Repression
The temporal relationship between ICER induction and inhibin
-subunit gene repression after LH administration was examined using
the immature rat model. RNAs prepared from granulosa cells that had
been isolated from the ovaries of rats treated with PMSG for various
times or treated with PMSG for 48 h followed by hCG for various
times were used to assess ICER and inhibin
-subunit mRNA expression.
As shown in Fig. 9
, the levels of inhibin
-subunit mRNA increased in response to PMSG stimulation and peaked
at 48 h of hormone treatment. After hCG administration, inhibin
-subunit mRNA was substantially decreased by 4 h and had
returned to basal levels by 12 h of hormone treatment. In these
same RNA samples, ICER mRNAs were not affected by PMSG treatment, were
strongly induced within 1 h of hCG treatment, and thereafter were
down-regulated. Thus, there is a tight temporal correlation between the
onset of ICER expression and the hCG-induced suppression of inhibin
-subunit gene expression.
To extend these studies to examine the expression of ICER protein in
the ovary, protein extracts were prepared from the granulosa cell and
thecal-interstitial cell fractions of hormonally treated immature rats.
Western protein blots were performed using an anti-CREM antibody that
detects ICER (32). As shown in Fig. 10A
, in the thecal-interstitial
fraction three protein species ranging from 1720 kDa were induced at
low levels within 4 h of PMSG treatment and declined to basal
levels by 48 h after PMSG treatment. Subsequent hCG treatment
rapidly induced ICER proteins in these cells. ICER protein expression
peaked at 4 h after hCG treatment and was down-regulated by
12 h after hCG treatment. In the granulosa cell fraction, shown in
Fig. 10B
, ICER proteins were also induced at 4 h after hCG
treatment and then down-regulated (PMSG alone had no effect on
granulosa cell ICER protein expression, consistent with the mRNA
results). These results indicate that ICER protein is maximally
expressed at 4 h after hCG stimulation, corresponding closely to
the time when inhibin
-subunit mRNA begins to decrease.

View larger version (42K):
[in this window]
[in a new window]
|
Figure 10. Expression of ICER Protein in the Rat Ovary
Western protein blot analysis of ICER expression in lysates from the
thecal and interstitial cell-enriched fraction (panel A) or the
granulosa cell-enriched fraction (panel B) of gonadotropin-stimulated
rat ovaries. Immature rats were treated with hormones as indicated, and
the ovaries were used to prepare granulosa and thecal-interstitial
fractions as described in legend to Fig. 6 . Detection was with an
anti-CREM antibody that detects the ICER protein, and the ICER proteins
are indicated by the bracket. The positions of mol wt
standards are also indicated. In Panel A, 5 µg of lysate from HeLa T4
cells transfected with an ICER I expression clone, as described in
Materials and Methods, were used as positive control
(ICER).
|
|
To establish whether the ICER protein can directly interact with the
nonconsensus CRE element in the inhibin
-subunit promoter,
electrophoretic mobility shift assays were performed. A radiolabeled
double-stranded oligonucleotide probe corresponding to the inhibin
-subunit CRE was incubated with whole cell extracts from GRMO2 cells
that were transiently transfected with an ICER I isoform expression
construct using a vaccinia virus-T7 RNA polymerase-based system (50).
As shown in Fig. 11
, this extract
produced a shift of the
-inhibin CRE probe that could be competed
with an excess of the unlabeled
-inhibin CRE or a consensus CRE, but
not with a nonspecific oligonucleotide. This band was not observed when
extracts from nontransfected GRM02 cells were used. When an antibody
against the CREM protein (which detects ICER) was included in the
incubation, a supershifted complex of lesser mobility was observed,
indicating that ICER is a component of the protein complex formed on
the inhibin
-subunit CRE.
To determine directly if ICER could act as a functional repressor of
the inhibin
-subunit gene, the same ICER I expression construct
described above was used. This construct, or an antisense control, was
cotransfected into the GRMO2 granulosa cell line along with an inhibin
-subunit promoter-luciferase reporter construct, and basal and
forskolin-induced luciferase activity was measured. Figure 12A
shows the structures of the two
constructs used, while Fig. 12B
shows the luciferase activities
normalized for total protein. As expected, the inhibin
-subunit
promoter was induced by forskolin in these cells, although the
induction is modest at this early time after forskolin stimulation (4
h). The sense ICER construct substantially reduced both basal and
forskolin-induced promoter activity, while the antisense ICER construct
had essentially no effect. These studies indicate that ICER-I can act
as a functional repressor of basal and cAMP-stimulated inhibin
-subunit gene expression in granulosa cells.
 |
DISCUSSION
|
---|
Hormonal signals that are transduced through cAMP-dependent
mechanisms in many tissues and cell types lead to the activation of
cAMP-responsive transcription factors such as CREB, CREM, and the
activating transcription factors (ATFs) (22, 51, 52). Tremendous
diversity in the forms and actions of these factors is likely to
provide for the fine tuning of cAMP-dependent transcriptional responses
in such target cells. This diversity is generated at multiple levels,
including numerous related genes encoding bZip factors (53), the use of
alternative promoters and RNA processing to produce mRNAs encoding
functionally distinct proteins (26, 30, 39, 54), the posttranslational
modification of these factors by phosphorylation (33, 55, 56), and the
ability of these factors to dimerize and heterodimerize in a
combinatorial fashion to generate specificity for distinct types of DNA
response elements (38, 55, 57, 58, 59, 60). Of particular interest for this
study, unique products of the CREB and CREM genes can act either as
cAMP-regulated activators or repressors of target gene transcription
(30, 35, 39). Perhaps the best characterized of the repressor isoforms
is the ICER, and in this report we describe the expression and
regulation of ICER in the rat ovary and test the hypothesis that ICER
is an important regulator of a model cAMP-responsive target gene, the
inhibin
-subunit gene.
Unlike CREB, which is fairly ubiquitously expressed, CREM and its
isoforms are expressed in a tissue- and cell-specific manner (27). In
particular, CREM isoforms are often highly expressed and regulated in
neuroendocrine tissues and cells, with well studied examples being the
pineal gland (40, 61) and the testis (30, 37, 62). We therefore sought
initially to establish whether CREM was expressed in the ovary and
whether its expression was regulated. Using several different animal
models (immature female rats treated with exogenous gonadotropins or
adult female rats progressing through the estrous cycle) we found that
CREM is expressed in the ovary and that CREM mRNA is induced by the
gonadotropins, particularly hCG or LH. Our data also indicate that the
inducible CREM transcripts found in the ovary correspond to mRNAs
encoding the previously reported isoforms of the repressor ICER, and
that ICER mRNAs are expressed in several cell types in the ovary but
are selectively induced in the granulosa cells of preovulatory
follicles in response to hCG or LH. We also found that ICER proteins
are induced in the ovary in response to the gonadotropins and that
maximal protein expression is delayed several hours beyond RNA
expression, as expected. Using primary cultures of rat granulosa cells
or the immortalized mouse granulosa cell line GRMO2, we demonstrate
that ICER gene expression can be induced by a variety of treatments
known to increase intracellular cAMP levels, and that ICER induction
involves the actions of PKA, as assessed by sensitivity to the PKA
inhibitor H89. Finally, there is a very strong temporal association
between ICER mRNA and induction and inhibin
-subunit mRNA
down-regulation in response to hCG treatment in immature rats or the
preovulatory LH surge in adult cycling rats.
The above studies indicate that ICER is induced in the appropriate cell
type, the granulosa cell, and at the appropriate time, after the LH
surge, to play a role in mediating the down-regulation of
FSH-stimulated ovarian genes such as the inhibin
-subunit gene. To
test directly whether ICER is able to impact the regulation of the
inhibin
-subunit gene, we first demonstrated that ICER can interact
with the nonconsensus CRE found in the inhibin
-subunit promoter
using gel mobility shift and antibody supershift approaches. We next
overexpressed ICER in a granulosa cell line and assessed the effect of
excess ICER on inhibin
-subunit gene expression. Our finding that
ICER can substantially repress both basal and cAMP-stimulated
expression of this gene in vitro is supportive of a direct
role for ICER in the regulation of inhibin
-subunit gene expression
in vivo.
Based on our previous studies of gonadotropin-induced CREB
phosphorylation in the ovary (41) and the findings presented here on
gonadotropin-induced ICER expression, we can propose a model for how
FSH and LH might exert their opposing actions on inhibin
-subunit
gene expression in ovarian granulosa cells. During the follicular phase
of the estrous cycle, FSH stimulates the proliferation of ovarian
granulosa cells, and this is accompanied by increasing expression of
the inhibin
-subunit gene. FSH, by stimulating intracellular cAMP
production and activating PKA, also induces the phosphorylation of CREB
on serine 133, making it competent to transactivate CRE-containing
target genes such as the inhibin
-subunit gene (41, 42). Once
ovarian granulosa cells acquire functional LH receptors, the
preovulatory LH and FSH surges trigger granulosa cell differentiation
and subsequent luteinization. The LH surge, through cAMP and
PKA-dependent pathways, also transiently induces the transcription of
the four ICER mRNAs. We propose that one function of ICER is to rapidly
repress the transcription of CRE-containing and CREB-activated target
genes such as the inhibin
-subunit gene. ICER itself is then
down-regulated through an autoregulatory mechanism, thus completing a
cycle of cAMP-dependent gene activation and repression (39).
A question of primary importance with respect to this model is why FSH
and LH, both acting predominantly through cAMP-dependent mechanisms,
have such divergent actions? One likely answer is provided by our data
showing that FSH (PMSG) treatment induces ICER in thecal and
interstitial cells, but not in granulosa cells. Whether this represents
the weak LH-like activity of PMSG on luteal and interstitial cell LH
receptors or a direct FSH effect is not known, but in either case ICER
is not induced in granulosa cells in vivo by this hormonal
treatment associated with granulosa cell proliferation and inhibin
-subunit mRNA induction. A second likely answer comes from studies
on ICER activation by cAMP signaling. The CREM intronic P2 promoter
includes four clustered CRE-like elements termed CAREs, or
cAMP-autoregulatory elements (39). These elements mediate cAMP
induction through activating factors such as CREB, and subsequently
bind ICER, resulting in an autorepression of ICER expression and a
resetting of the system. Because several of the CAREs are fairly poor
consensus CRE elements, it is possible that they are occupied by
activators only when the cAMP-PKA-signaling pathway is fully activated.
The magnitude of the intracellular cAMP signal generated in the
granulosa cells of preovulatory follicles by the LH surge is much
larger than that generated by FSH in the granulosa cells of maturing
follicles (19, 20), providing a potential mechanism for the selective
activation of ICER by LH in vivo. Our studies showing that
ICER expression can also be induced in vitro by high doses
of recombinant FSH are consistent with the idea that the magnitude of
the cAMP signal is a critical determinant of the ICER response.
The CREM gene has been disrupted by homologous recombinant in embryonic
stem cells, and the homozygous mutant mice generated from these cells
lack both CREM and ICER expression (63, 64). The male mutant mice
exhibit severe defects in spermatogenesis, consistent with a proposed
role of CREM and ICER in this process (63, 64). Paradoxically, the
female mutant mice are reported to be fertile, although detailed
studies of reproductive phenotypes in the female have not yet been
reported. This finding might suggest that ICER is not critical as a
transcriptional regulator during LH-induced ovulation and luteinization
in the rodent ovary. An alternative explanation is that other factors
are able to compensate for the loss of ICER expression in the ovary.
For example, similar repressor forms of the CREB gene are expressed
through alternative RNA processing mechanisms in the testis (35). While
we did not detect RNAs for these repressor forms of CREB in the ovary
of normal animals (41), they might be induced in the ovary in the
absence of ICER in the mutant animals and serve a similar function. It
is also unlikely that ICER is the only factor involved in the
repression of cAMP-induced gene expression in response to the LH surge.
Indeed, ICER expression in granulosa cells is very transient, whereas
there is an extended down-regulation of target genes such as the
inhibin
-subunit gene, which remains repressed in luteinized cells
in the rodent ovary (5, 65). It has recently been shown that LH
treatment leads to a down-regulation of steroidogenic factor-1 (SF-1)
protein in rat granulosa cells, and this appears to be an important
part of the mechanism that underlies the down-regulation of rat
aromatase CYP19 gene expression (66). The inhibin
-subunit gene
promoter contains several consensus SF-1 binding sites, and SF-1 is
likely to be involved in its regulation in granulosa cells. An
additional factor that is likely to be important for down-regulation of
cAMP-regulated genes is the bZip protein C/EBPß (67). Recent studies
indicate that female mice homozygous for a disruption of the C/EBPß
gene are infertile and exhibit defects in ovulation (68).
Interestingly, several genes that are normally down-regulated by the LH
surge, including aromatase and prostaglandin endoperoxide synthase-2
(PGS-2), fail to be down-regulated in the ovaries of the C/EBPß
mutant mice (68). C/EBPß mRNA is rapidly induced by hCG in granulosa
cells (66), but peak levels of C/EBPß mRNA in preovulatory follicles
are not observed until 47 h after hormone administration (68). Thus,
C/EBPß might be critical for the longer term repression of this class
of genes, whereas ICER might play a more predominant role in the
immediate early responses to the LH surge. Further studies of the roles
of transcription factors such as SF-1 and C/EBPß in inhibin
-subunit gene expression should be informative in this regard.
The dephosphorylation of CREB attenuates its transcriptional activity
(69, 70), and this represents another important mechanism for
suppressing cAMP-induced transcriptional responses. However, we have
previously reported that hCG rapidly stimulates CREB phosphorylation in
PMSG-primed rat granulosa cells (41), suggesting that CREB
dephosphorylation cannot fully explain the ability of LH to attenuate
FSH-induced gene expression in granulosa cells. Furthermore, ICER mRNA
induction requires CREB (71), indicating that CREB is likely to be
phosphorylated and active at the time of the LH surge. Recent studies
in pituitary AtT20 cells have investigated the relative contributions
of CREB dephosphorylation and ICER induction in attenuating
cAMP-induced transcriptional responses and also addressed the important
concept of the dynamics of cAMP-induced transcriptional responses (72).
These experiments and others define a refractory period after the
initial stimulation of cAMP-dependent genes that is determined in part
by the duration of the initial stimulus (73, 74). These findings may
have strong parallels in the ovary that would help to explain our data
showing that while the primary gonadotropin surges on proestrus evening
strongly induce ICER expression, the secondary FSH surge early on the
morning of estrus does not. The intense and sustained primary LH surge
that induces ICER expression might, in addition to initiating the
events that lead to target gene repression, serve to make granulosa
cells refractory to further ICER induction in response to the secondary
FSH surge, thus allowing FSH to act in a stimulatory fashion to induce
the gene expression and cell proliferation events that are critical to
the recruitment and maturation of a new cohort of ovarian follicles. It
seems reasonable to speculate that cycles of gonadotropin-induced and
cAMP-mediated induction and attenuation of transcriptional responses
may be a key mechanistic component for maintaining the cycles of
ovarian follicular development characteristic of reproduction in many
mammals.
 |
MATERIALS AND METHODS
|
---|
Animals and Hormone Treatments
Immature 21- to 23-day-old female Sprague-Dawley rats (Harlan
Breeding Laboratories, Indianapolis, IN), were kept on 14-h, 10-h
light-dark cycles with lights on at 0500 h. Rats were injected
with PMSG (10 IU, sc, Sigma, St. Louis, MO) for up to 48 h and
later with hCG (10 IU, ip, Sigma) for up to 12 h. Rats were killed
at various time points, and ovaries were removed and either used
immediately to isolate granulosa cells or rapidly frozen on dry ice and
stored at -80 C for later use. Adult female Sprague Dawley rats (body
weight 150180 g, Charles Rivers Breeding Laboratories, Wilmington,
MA) were maintained as described above. Estrous cycle stages were
determined by daily examination of vaginal cytology. Only animals that
showed at least two consecutive 4-day cycles were used. Rats were
killed and ovaries removed at 0900 and 1800 h on each day of the
cycle as well as at 1200, 1400, 1600, 2000, and 2200 h on
proestrus and 0200 h on estrus. Ovaries were frozen rapidly on dry
ice and stored at -80 C until use. Trunk blood was collected for
gonadotropin measurements. FSH and LH were determined by RIA using rat
FSH-RP-2 and LH-RP-3 from NIDDK as standards (75). Intra- and
interassay coefficients of variation were less than 10% in both
assays. For antagonist experiments, rats were injected with
pentobarbitol (40 mg/kg in saline, ip, Sigma) or the GnRH antagonist
WY-45760 (100 µg/rat in sesame oil, sc, Wyeth Laboratories,
Philadelphia, PA) at 1330 and 1200 h, respectively, on proestrus.
Rats treated with vehicle alone served as controls, and animals were
killed for analysis at 1800 h proestrus.
Granulosa Cell Cultures
Immature 21- to 23-day old female rats with or without PMSG
treatment (10 IU, sc, for 24 h) were used for granulosa cell
preparation utilizing follicular puncture essentially as described (42, 76). Ovaries were collected into serum-free medium (4F), which consists
of 15 mM HEPES, pH 7.4, 50% DMEM, and 50% Hams F12 with
transferrin (5 µg/ml), human insulin (2 µg/ml), hydrocortisone (40
ng/ml), and antibiotics. After incubating the ovaries at 37 C in 4F
medium containing 0.5 M sucrose and 10 mM EGTA
for 30 min, the ovaries were washed in fresh 4F medium. Individual
follicles were punctured, and the granulosa cells were extruded using a
23 ga needle under a Reichert dissection microscope (Buffalo, NY).
Cells were plated in 4F medium supplemented with 10% FBS (GIBCO BRL,
Grand Island, NY), and incubated in a humidified atmosphere of 5%
CO2 at 37 C. Cultured cells were either untreated or
treated in vitro with 10 µM forskolin (Sigma),
varying doses of hCG, or recombinant human FSH (line 1, sample 329,
NICHD).
Isolation of CREM and ICER cDNAs
Rat CREM cDNAs were cloned from total testicular RNA by RT-PCR
using oligonucleotide primers 1 and 2 (see Fig. 1
) corresponding to
nucleotide positions 1536 and 11151135, respectively, of the mouse
CREM cDNA (27). DNA sequence analysis indicated that cDNAs encoding the
and
2 isoforms of CREM protein were obtained. Total RNA isolated
from the ovary of an adult rat at 1800 h proestrus was used to
clone ICER cDNAs by RT-PCR. Oligonucleotide primer 4 corresponding to
nucleotides 121 of ICER cDNA (39) and oligonucleotide primer 2 were
used for PCR amplification. All oligonucleotide primers were purchased
from Cruachem (Sterling, VA). The ICER-I expression construct was made
by cloning the ICER-I RT-PCR product (see Fig. 1
) into the expression
vector pcDNA-3 (Invitrogen, San Diego, CA), which includes the human
cytomegalovirus (CMV) promoter and 3'-polyadenylation sequences from
the bovine GH gene.
RNA Isolation and Analysis
RNA from ovaries or granulosa cells was isolated by
homogenization in 4 M guanidine isothiocyanate containing
25 mM sodium citrate, 0.5% sarkosyl, and 7
µM ß-mercaptoethanol and extraction with acid-phenol
(77) or by centrifugation through CsCl gradients. For RT-PCR assays,
total ovarian RNA was reverse transcribed using avian myeloblastosis
virus (AMV) reverse transcriptase in the presence of
deoxynucleosidetriphosphates (1 mM) and random hexameric
oligonucleotides, and aliquots of this cDNA were amplified by PCR with
incorporation of [32P]dCTP into the PCR product as
described previously (78). PCR primers 2 and 4 (see Fig. 1
) and primers
specific for the inhibin
-subunit (79) were used. Rat ribosomal
protein L-19 (80) was used as an internal control in all experiments.
The PCR products were separated by size using electrophoresis on 5%
polyacrylamide gels, the gels were dried, and PCR products were
visualized by autoradiography on X-OMAT-AR film (Eastman Kodak Company,
Rochester, NY) and quantified using a PhosphorImager and ImageQuant
software (Molecular Dynamics, Sunnyvale, CA). For Northern RNA blot
analysis, 20 µg total RNA were separated by size using
electrophoresis in a 1.2% agarose gel containing 1x
3-[N-morpholino]propane-sulfonic acid (MOPS) buffer and
6% formaldehyde (81) and visualized by acridine orange staining.
Size-fractionated RNA was transferred to Biotrans Nylon membrane (ICN,
Irvine, CA), immobilized on the membrane by UV cross-linking and baking
at 80 C for 30 min. A 47-nucleotide antisense oligonucleotide, primer 3
(see Fig. 1
) corresponding to nucleotide positions -1 to -47 (39)
unique for ICER was end-labeled with [32P]dCTP and
terminal deoxynucleotide transferase and used as the hybridization
probe. The blots were washed at a final stringency of 0.1x saline
sodium citrate (SSC)/0.01% SDS at 65 C. ICER mRNA was visualized by
autoradiography on X-OMAT-AR film (Eastman Kodak). Radioactive signal
from the blot was removed by washing in 10 mM sodium
phosphate (pH 6.5) in 50% formamide at 65 C for 1 h, followed by
2x SSC/0.1% SDS at room temperature for 15 min. The blot was then
hybridized to a ribosomal protein S2 (82) probe, prepared by random
priming, as a control to compare the amounts of RNA loaded and
transferred.
In Situ Hybridization
Sections (20-µm) of frozen ovaries were prepared using a
Reichert 820 cryostat and mounted onto gelatin and poly
L-lysine-coated glass slides for in situ
hybridization as described previously (78). Hybridization probes used
were [35S]UTP or [33P]UTP-labeled
riboprobes derived from the full-length
2 CREM cDNA clone, a
5'-NcoI subclone (see Fig. 1
) of rat CREM
2, a rat
LH receptor cDNA subclone, or a [35S]dATP-labeled
47-nucleotide long antisense oligonucleotide that is unique to ICER
isoform (primer 3 in Fig. 1
). Hybridization was continued for 1218 h
at 47 C in a humidified chamber. Sense riboprobes were used as
controls. Subsequently, the slides were washed to a final stringency of
0.1x SSC at 65 C after a 1-h treatment with 20 µg/ml RNAse at 37 C.
Slides were then processed for emulsion autoradiography (NTB-2, Eastman
Kodak). Exposure time on emulsion was 2 weeks. After development of the
slides, they were stained with hematoxylin to visualize nuclei. The
sections were then examined and photographed using a macroscope (Wild
M420, Leica, Heerbrugg, Switzerland) or a Nikon Optiphot microscope
(Nippon Kogaku, Inc., Garden City, NY).
Preparation of Protein Extracts and Western Blot Analysis
Protein lysates were prepared in lysis buffer (50 mM
Tris-HCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150
mM NaCl, 1 mM EGTA, 1 mM
phenylmethylsulfonylfluoride, 1 µg/ml aprotinin, leupeptin,
aprotinin, 1 mM NaF). For cultured cells, after the cells
were washed with PBS and collected by low-speed centrifugation, they
were resuspended in lysis buffer and incubated on ice for 10 min and
then lysed by two cycles of freezing and thawing. The lysates were
centrifuged to remove nuclear debris, and the supernatant was collected
and frozen at -80 C until further use. Frozen tissue samples were
pulverized in dry ice and homogenized in lysis buffer using six to
eight strokes with a Dounce homogenizer. This homogenate was subjected
to two cycles of freezing and thawing and processed as described above.
Protein concentrations were estimated using a Bradford colorimetric
assay (Bio-Rad, Richmond, CA).
Protein lysates (100 µg) were boiled for 5 min in denaturing sample
buffer and size separated on a 1018% continuous gradient
SDS-polyacrylamide gel, and proteins were transferred to nitrocellulose
(BA-85, Shleicher & Schuell, Keene NH). The membrane was washed with
water and blocked with 3% nonfat dry milk in PBS (blocking buffer) for
30 min at room temperature with shaking. The blot was then incubated
with primary antibody (anti-CREM at 1:250) in blocking buffer for
48 h at 4 C with gentle shaking. The blot was washed two times
with water and once with PBS followed by a 45-min incubation at room
temperature with goat antirabbit antibody conjugated to horseradish
peroxidase (Promega, Madison WI) in blocking buffer. The blot was then
washed twice with water, once with PBS, and once with PBS containing
0.05% Tween 20. The blot was rinsed with water, and antibody-antigen
complexes were visualized using an enhanced chemiluminescence system
(ECL kit, Amersham. Little Chalfont, Buckinghamshire, U.K.).
GRMO2 Cell Culture, Transfection, and Luciferase Assays
GRMO2 cells (provided by N.V. Innogenetics, Ghent, Belgium)
were cultured as described (47, 48) in HDTIS (DMEM-F12 1:1, 10 µg/ml
insulin, 5 nM sodium selenite, 5 µg/ml transferrin)
supplemented with 2% FBS and sodium pyruvate (100 mg/liter) in a
humidified incubator at 37 C and 5% CO2. GRMO2 cells were
either untreated or treated in vitro with 10
µM forskolin, varying doses of hCG, or recombinant human
FSH with or without the PKA inhibitor H89 (Sigma). Cationic liposomes,
prepared as described previously (83), were used for transient
transfection of GRMO2 cells with DNA (84). Plasmid DNA (2.5 µg) for
each well of a 12-well culture dish was incubated at room temperature
with lipofection reagent for 2030 min in OptiMEM and added to cells
washed with PBS. After 6 h, the DNA-lipid mixture was replaced
with fresh HDTIS containing 2% FBS, and the cells were incubated for
12 h. Fresh medium, or medium containing 10 µM
forskolin, was then added to the cells. After 4 h of hormone
treatment, the cells were washed with PBS and lysed by gently agitating
on ice in sample buffer (25 mM HEPES, pH 7.8, 15
mM MgSO4, 1 mM dithiothreitol,
0.1% Triton X-100). Luciferase assays were performed essentially as
described (85). Cell lysates (100 µl) were added to 400 µl of assay
buffer (25 mM HEPES, pH 7.8, 15 mM
MgSO4, 5 mM ATP, 1 µg/ml BSA), and 100 µl
of 1 mM luciferin (sodium salt) (Analytical
Bioluminescence, San Diego, CA) were added using an automatic injector;
emitted luminescence was measured using a 2010 luminometer (Analytical
Bioluminescence) for 10 sec. Cell lysates (20 µl) were used for total
protein determination using the Bio-Rad protein assay reagent. For
Western blot analysis and electromobility shift assays, the vaccinia-T7
RNA polymerase hybrid expression system (50) was used. GRMO2 or HeLaT4
cells were infected with vaccinia virus vTF7.3 expressing the
bacteriophage T7 RNA polymerase (obtained under license from Dr.
Bernard Moss, NIH, Bethesda, MD) at a multiplicity of infection of 10
for 3040 min in PBS/0.1% BSA. Virus was aspirated, and preincubated
DNA-liposome mixture was added to the cells and incubated for 12
h. Cells were immediately harvested and processed for protein
isolation.
Electrophoretic Mobility Shift Assays
A 20-bp double-stranded oligonucleotide probe that spans the
inhibin
- subunit CRE sequence was end labeled using
[32P-
]ATP and T4 polynucleotide kinase (Promega,
Madison, WI) and purified using a G-25 spin column (Boehringer Mannheim
GmbH, Mannheim, Germany). Whole-cell lysates (5 µg) from
vaccinia-infected transfected cells were used for each binding
reaction. Whole-cell lysates, prepared as described earlier in this
section, were incubated in binding buffer [50 mM Tris-HCl,
pH 7.9, 12.5 mM MgCl2, 10% glycerol (vol/vol),
0.5 mM dithiothreitol, 50 ng/µl poly
deoxy(inosinic-cytidylic)acid] for 20 min at room temperature with 1
ng of 32P-labeled oligonucleotide probe. Where indicated,
100 ng of double-stranded unlabeled competitor oligonucleotide were
added to the binding reaction 5 min before the addition of probe. For
antibody supershift studies, 1 µl of anti-CREM antibody was added to
the reaction, and the reaction was incubated at room temperature for an
additional 20 min. The protein-DNA complexes were resolved on a native
5% polyacrylamide-Tris-borate-EDTA gel. The gel was dried and
exposed to x-ray film (Kodak XAR).
 |
ACKNOWLEDGMENTS
|
---|
We thank N.V. Innogenetics (Ghent, Belgium), for providing us
with the GRMO2 cell line, and Dr. Hugo Vanderstichele (N. V.
Innogenetics) for advice on growth of the cells. We are grateful to
Drs. Jon Kornhauser (Childrens Hospital, Boston, MA), Daniel Linzer
(Northwestern University, Evanston, IL), and Mary Hunzicker-Dunn
(Northwestern University, Chicago, IL) for helpful comments on these
experiments. We thank Janelle Roby (Northwestern University, Evanston,
IL) for help with in situ hybridization studies. We also
thank NIDDK and NICHD for providing us with hormone-measurement
reagents and recombinant FSH.
 |
FOOTNOTES
|
---|
Address requests for reprints to: K. E. Mayo, Department of Biochemistry, Molecular Biology and Cell Biology, Northwestern University, Evanston, Illinois 60208.
This work was supported by NIH P01 Grant HD-21921 and NIH P30 Center
Grant HD-28048 (to K.E.M.).
Received for publication October 28, 1997.
Revision received March 5, 1998.
Accepted for publication March 11, 1998.
 |
REFERENCES
|
---|
-
Woodruff TK, Mather JP 1995 Inhibin, activin and the
female reproductive axis. Annu Rev Physiol 57:219244[CrossRef][Medline]
-
Segaloff DL, Wang HY, Richards JS 1990 Hormonal regulation of
luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian
cells during follicular development and luteinization. Mol Endocrinol 4:18561865[Abstract]
-
LaPolt PS, Oikawa M, Jia XC, Dargan C, Hsueh AJ 1990 Gonadotropin-induced up- and down-regulation of rat ovarian LH receptor
message levels during follicular growth, ovulation and luteinization.
Endocrinology 126:32773279[Abstract]
-
Mayo KE 1994 Inhibin and activin. Molecular aspects of
regulation and function. Trends Endocrinol Metab 5:407415
-
Dykema J, Rahal J, Mayo K 1991 Regulation of inhibin and
activin genes in the rat ovary. In: Gibori G (ed) Signaling Mechanisms
and Gene Expression in the Ovary. Serono Symposia USA, Springer-Verlag,
New York, pp 99111
-
Hickey G, Chen S, Besman M, Shively J, Hall P, Gaddy-Kurten
D, Richards J 1988 Hormonal regulation, tissue distribution, and
content of aromatase cytochrome P450 mRNA and enzyme in rat ovarian
follicles and corpora lutea: relationship to estradiol biosynthesis.
Endocrinology 122:14261436[Abstract]
-
Camp TA, Rahal JO, Mayo KE 1991 Cellular localization and
hormonal regulation of follicle-stimulating hormone and luteinizing
hormone receptor messenger RNAs in the rat ovary. Mol Endocrinol 5:14051417[Abstract]
-
Woodruff T, Mayo K 1990 Regulation of inhibin synthesis in
the rat ovary. Annu Rev Physiol 52:807821[CrossRef][Medline]
-
Richards JS, Fitzpatrick SL, Clemens JW, Morris JK, Alliston
T, Sirois J 1995 Ovarian cell differentiation: a cascade of multiple
hormones, cellular signals, and regulated genes. Recent Prog Horm Res 50:223254[Medline]
-
Mcfarland K, Sprengel R, Phillips H, Kohler M, Rosemblit N,
Nickolics K, Segaloff D, Seeburg P 1989 Lutropin-choriogonadotropin
receptor: an unusual member of the G-protein coupled receptor family.
Science 245:494499[Medline]
-
Sprengel R, Braun T, Nikolics K, Segaloff D, Seeburg P 1990 The testicular receptor for FSH: structure and functional expression of
cloned cDNA. Mol Endocrinol 4:525530[Abstract]
-
Richards J 1987 Ovarian follicular development: from
physiology to molecular biology. Recent Prog Horm Res 43:231276[Medline]
-
Hunzicker-Dunn M, Birnbaumer L 1985 The stimulation of
adenylyl cyclase and cAMP dependent protein kinases in luteinizing
hormone action. In: Ascoli M (ed) Luteinizing Hormone Action and
Receptors. CRC Press, Boca-Raton, FL, pp 57134
-
Gudermann T, Birnbaumer M, Birnbaumer L 1992 Evidence for dual
coupling of the murine LH receptor to adenylyl cyclase and
phosphoinositide breakdown and Ca+2 mobilization. J Biol Chem 267:44794488[Abstract/Free Full Text]
-
Morris JK, Richards JS 1995 Luteinizing hormone induces
prostaglandin endoperoxide synthase-2 and luteinization in
vitro by A-kinase and C-kinase pathways. Endocrinology 136:15491558[Abstract]
-
Morris JK, Richards JS 1993 Hormone induction of luteinization
and prostaglandin endoperoxide synthase-2 involves multiple cellular
signaling pathways. Endocrinology 133:770779[Abstract]
-
Uilenbroek JT, Richards JS 1979 Ovarian follicular development
during the rat estrous cycle: gonadotropin receptors and follicular
responsiveness. Biol Reprod 20:11591165[Medline]
-
Richards JS 1979 Hormonal control of ovarian follicular
development: a 1978 perspective. Recent Prog Horm Res 35:343373[Medline]
-
Richards J, Bogovich K 1982 Effects of human chorionic
gonadotropin and progesterone on follicular development in the immature
rat. Endocrinology 111:14291438[Medline]
-
Jonassen JA, Bose K, Richards JS 1982 Enhancement and
desensitization of hormone-responsive adenylate cyclase in granulosa
cells of preantral and antral ovarian follicles: effects of estradiol
and follicle-stimulating hormone. Endocrinology 111:7479[Abstract]
-
Landschulz W, Johnson P, McKnight S 1988 The leucine zipper: a
hypothetical structure common to a new class of DNA binding proteins.
Science 240:17591764[Medline]
-
Sassone-Corsi P 1995 Transcription factors responsive to cAMP.
Annu Rev Cell Dev Biol 11:355377[CrossRef][Medline]
-
Meyer TE, Habener JF 1993 Cyclic adenosine 3',5'-monophosphate
response element binding protein (CREB) and related
transcription-activating deoxyribonucleic acid-binding proteins. Endocr
Rev 14:269290[Medline]
-
Hoeffler JP, Meyer T, Yun Y, Jameson JL, Habener JF 1988 Cyclic AMP-responsive DNA-binding protein: structure based on a cloned
placental cDNA. Science 242:14301433[Medline]
-
Gonzalez G, Yamamoto K, Fischer W, Karr D, Menzel P, Biggs III
W, Vale W, Montminy M 1989 A cluster of phosphorylation sites on the
cyclic AMP responsive regulated nuclear factor CREB predicted by its
sequence. Nature 337:749752[CrossRef][Medline]
-
Waeber G, Meyer TE, LeSieur M, Hermann HL, Gerard N, Habener
JF 1991 Developmental stage-specific expression of cyclic adenosine
3',5'-monophosphate response element-binding protein CREB during
spermatogenesis involves alternative exon splicing. Mol Endocrinol 5:14181430[Abstract]
-
Foulkes NS, Borrelli E, Sassone-Corsi P 1991 CREM gene: use of
alternative DNA-binding domains generates multiple antagonists of
cAMP-induced transcription. Cell 64:739749[Medline]
-
Laoide B, Foulkes N, Schlotter F, Sassone-Corsi P 1993 The
functional versatility of CREM is determined by its modular structure.
EMBO J 12:11791191[Abstract]
-
Lalli E, Lee JS, Lamas M, Tamai K, Zazopoulos E, Nantel F,
Penna L, Foulkes NS, Sassone-Corsi P 1996 The nuclear response to cAMP:
role of transcription factor CREM. Philos Trans R Soc Lond [Biol] 351:201209[Medline]
-
Foulkes N, Mellstrom B, Benusiglio E, Sassone-Corsi P 1992 Developmental switch of CREM during spermatogenesis: from antagonist to
transcriptional activator. Nature 355:8084[CrossRef][Medline]
-
Ruppert S, Cole TJ, Boshart M, Schmid E, Schutz G 1992 Multiple mRNA isoforms of the transcription activator protein CREB:
generation by alternative splicing and specific expression in primary
spermatocytes. EMBO J 11:15031512[Abstract]
-
Delmas V, Laoide B, Masquilier D, de Groot R, Foulkes N,
Sassone-Corsi P 1992 Alternative usage of initiation codons in mRNA
encoding the cAMP modulator generates regulators with opposite
functions. Proc Natl Acad Sci USA 89:42264230[Abstract]
-
Gonzalez G, Montminy M 1989 Cyclic AMP stimulates somatostatin
gene transcription by phosphorylation of CREB at serine 133. Cell 59:675680[Medline]
-
Berkowitz L, Gilman M 1990 Two distinct forms of active
transcription factor CREB (cAMP response element binding protein). Proc
Natl Acad Sci USA 87:52585262[Abstract]
-
Walker WH, Girardet C, Habener JF 1996 Alternative exon
splicing controls a translational switch from activator to repressor
isoforms of transcription factor CREB during spermatogenesis. J
Biol Chem 271:2014520150[Abstract/Free Full Text]
-
Masson N, Hurst HC, Lee KA 1993 Identification of proteins
that interact with CREB during differentiation of F9 embryonal
carcinoma cells. Nucleic Acids Res 21:11631169[Abstract]
-
Walker WH, Sanborn BM, Habener JF 1994 An isoform of
transcription factor CREM expressed during spermatogenesis lacks the
phosphorylation domain and represses cAMP-induced transcription. Proc
Natl Acad Sci USA 91:1242312427[Abstract/Free Full Text]
-
Ellis MJ, Lindon AC, Flint KJ, Jones NC, Goodbourn S 1995 Activating transcription factor-1 is a specific antagonist of the
cyclic adenosine 3'.5'-monophosphate (cAMP) response element-binding
protein-1-mediated response to cAMP. Mol Endocrinol 9:255265[Abstract]
-
Molina CA, Foulkes NS, Lalli E, Sassone-Corsi P 1993 Inducibility and negative autoregulation of CREM: an alternative
promoter directs the expression of ICER, an early response repressor.
Cell 75:875886[Medline]
-
Stehle JH, Foulkes NS, Molina CA, Simonneaux V, Pevet P,
Sassone-Corsi P 1993 Adrenergic signals direct rhythmic expression of
transcriptional repressor CREM in the pineal gland. Nature 365:314320[CrossRef][Medline]
-
Mukherjee A, Park-Sarge O-K, Mayo KE 1996 Gonadotropins induce
rapid phosphorylation of the 3',5'-cyclic adenosine monophosphate
response element binding protein in ovarian granulosa cells.
Endocrinology 137:32343245[Abstract]
-
Pei L, Dodson R, Schoderbek WE, Maurer RA, Mayo KE 1991 Regulation of the alpha inhibin gene by cyclic adenosine
3',5'-monophosphate after transfection into rat granulosa cells. Mol
Endocrinol 5:521534[Abstract]
-
Everett J, Sawyer C 1950 A 24-hour periodicity in the
"LH-releasing apparatus" of female rats, disclosed by barbitrate
sedation. Endocrinology 47:198218
-
Legan S, Karsch F 1975 A daily signal for the LH surge in the
rat. Endocrinology 96:5762[Abstract]
-
Hiatt ES, Schwartz NB 1989 Suppression of basal and
GnRH-stimulated gonadotropin secretion rate in vitro by GnRH
antagonist: differential effects on metestrous and proestrous
pituitaries. Neuroendocrinology 50:158164[Medline]
-
Papkoff H 1974 Chemical and biological properties of the
subunits of pregnant mare serum gnadotropin. Biochem Biophys Res Commun 58:397404[Medline]
-
Vanderstichele H, Delaey B, de Winter J, de Jong F, Rombauts
L, Verhoeven G, Dello C, van de Voorde A, Briers T 1994 Secretion of
steroids, growth factors, and cytokines by immortalized mouse granulosa
cell lines. Biol Reprod 50:11901202[Abstract]
-
Briers TW, van de Voorde A, Vanderstichele H 1993 Characterization of immortalized mouse granulosa cell lines. In Vitro
Cell Dev Biol 29A:847854
-
Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T,
Naito K, Toshioka T, Hidaka H 1990 Inhibition of forskolin-induced
neurite outgrowth and protein phosphorylation by a newly synthesized
selective inhibitor of cyclic AMP-dependent protein kinase,
N-{2-(p-bromocinnamylamino)-5-isoquinoleinsulfonamide (H89), of PC12D
pheochromocytoma cells. J Biol Chem 265:52675272[Abstract/Free Full Text]
-
Fuerst TR, Earl PL, Moss B 1987 Use of a hybrid vaccina
virus-T7 RNA polymerase system for expression of target genes. Mol Cell
Biol 7:253872544[Medline]
-
Borrelli E, Montmayeur JP, Foulkes NS, Sassone-Corsi P 1992 Signal transduction and gene control: the cAMP pathway. Crit Rev
Oncogen 3:321338[Medline]
-
Habener JF, Miller CP, Vallejo M 1995 cAMP-dependent
regulation of gene transcription by cAMP response element-binding
protein and cAMP response element modulator. Vitam Horm 51:157[Medline]
-
Meyer TE, Habener JF 1992 Cyclic AMP response element binding
protein CREB and modulator protein CREM are products of distinct genes.
Nucleic Acids Res 20:6106[Medline]
-
Waeber G, Habener JF 1992 Novel testis germ cell-specific
transcript of the CREB gene contains an alternatively spliced exon with
multiple in-frame stop codons. Endocrinology 131:20102015[Abstract]
-
Loriaux MM, Brennan RG, Goodman RH 1994 Modulatory function of
CREB.CREM alpha heterodimers depends upon CREM alpha phosphorylation.
J Biol Chem 269:2883928843[Abstract/Free Full Text]
-
Papavassiliou AG 1994 The CREB/ATF family of transcription
factors: modulation by reversible phosphorylation. Anticancer Res 14:18011805[Medline]
-
Masson N, John J, Lee KA 1993 In vitro
phosphorylation studies of a conserved region of the transcription
factor ATF1. Nucleic Acids Res 21:41664173[Abstract]
-
Masquilier D, Sassone-Corsi P 1992 Transcriptional cross-talk:
nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation
by Jun. J Biol Chem 267:2246022466[Abstract/Free Full Text]
-
Pescini R, Kaszubska W, Whelan J, DeLamarter JF, Hooft, van,
Huijsduijnen, R 1994 ATF-a0, a novel variant of the ATF/CREB
transcription factor family, forms a dominant transcription inhibitor
in ATF-a heterodimers. J Biol Chem 269:11591165[Abstract/Free Full Text]
-
Wollberg P, Söderqvist H, Nelson BD 1994 Mitogen
activation of human peripheral T lymphocytes induces the formation
of new cyclic AMP response element-binding protein nuclear
complexes. J Biol Chem 269:1971919724[Abstract/Free Full Text]
-
Foulkes NS, Duval G, Sassone-Corsi P 1996 Adaptive
inducibility of CREM as transcriptional memory of circadian rhythms.
Nature 381:8385[CrossRef][Medline]
-
Foulkes NS, Schlotter F, Pevet P, Sassone-Corsi P 1993 Pituitary hormone FSH directs the CREM functional switch during
spermatogenesis. Nature 362:264267[CrossRef][Medline]
-
Nantel F, Monaco L, Foulkes NS, Masquilier D, LeMeur M,
Henriksen K, Dierich A, Parvinen M, Sassone-Corsi P 1996 Spermiogenesis
deficiency and germ-cell apoptosis in CREM-mutant mice. Nature 380:159162[CrossRef][Medline]
-
Blendy JA, Kaestner KH, Weinbauer GF, Nieschlag E, Schutz G 1996 Severe impairment of spermatogenesis in mice lacking the CREM
gene. Nature 380:162165[CrossRef][Medline]
-
Woodruff TK, DAgostino J, Schwartz NB, Mayo KE 1988 Dynamic
changes in inhibin messenger RNAs in rat ovarian follicles during the
reproductive cycle. Science 239:12961299[Medline]
-
Carlone DL, Richards JS 1997 Functional interactions,
phosphorylation, and levels of 3',5'-cyclic adenosine
monophosphate-regulatory element binding protein and steroidogenic
factor-1 mediate hormone-regulated and constitutive expression of
aromatase in gonadal cells. Mol Endocrinol 11:292304[Abstract/Free Full Text]
-
Sirois J, Richards JS 1993 Transcriptional regulation of the
rat prostaglandin endoperoxide synthase 2 gene in granulosa cells.
Evidence for the role of a cis-acting C/EBP beta promoter element.
J Biol Chem 268:2193121938[Abstract/Free Full Text]
-
Sterneck E, Tessarollo L, Johnson P 1997 An essential role for
C/EBPß in female reproduction. Genes Dev 11:21532162[Abstract/Free Full Text]
-
Hagiwara M, Alberts A, Brindle P, Meinkoth J, Feramisco J,
Deng T, Karin M, Shenolikar S, Montminy M 1992 Transcriptional
attenuation following cAMP induction requires PP-1-mediated
dephosphorylation of CREB. Cell 70:105113[Medline]
-
Wadzinski BE, Wheat WH, Jaspers S, Peruski Jr LF, Lickteig RL,
Johnson GL, Klemm DJ 1993 Nuclear protein phosphatase 2A
dephosphorylates protein kinase A-phosphorylated CREB and regulates
CREB transcriptional stimulation. Mol Cell Biol 13:28222834[Abstract]
-
Servillo G, Penna L, Foulkes NS, Magni MV, Della Fazia MA,
Sassone-Corsi P 1997 Cyclic AMP signalling pathway and cellular
proliferation: induction of CREM during liver regeneration. Oncogene 14:16011606[CrossRef][Medline]
-
Lamas M, Sassone-Corsi P 1997 The dynamics of the response to
cyclic adenosine 3',5'-monophosphate: recurrent inducibility and
refractory phase. Mol Endocrinol 11:14151424[Abstract/Free Full Text]
-
Armstrong R, Wen W, Meinkoth J, Taylor S, Montminy M 1995 A
refractory phase in cyclic AMP-responsive transcription requires down
regulation of protein kinase A. Mol Cell Biol 15:18261832[Abstract]
-
Buscher M, Rahmsdorf H, Liftin M, Karin M, Herrlich P 1988 Activation of the c-fos gene by UV and phorbol ester:
different signal transduction pathways converge to the same enhancer
element. Oncogene 3:301311[Medline]
-
Knox K, Ringstrom S, Schwartz N 1993 RU486 blocks the effects
of inhibin antiserum or luteinizing hormone on the secondary
follicle-stimulating hormone surge. Endocrinology 133:277283[Abstract]
-
Park-Sarge O, Mayo K 1994 Regulation of the progesterone
receptor gene by gonadotropins and cyclic adenosine 3',5'-monophosphate
in rat granulosa cells. Endocrinology 134:709718[Abstract]
-
Chomczynski P, Sacchi N 1987 Single-step method of RNA
isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem 162:156159[CrossRef][Medline]
-
Park OK, Mayo KE 1991 Transient expression of progesterone
receptor messenger RNA in ovarian granulosa cells after the
preovulatory luteinizing hormone surge. Mol Endocrinol 5:967978[Abstract]
-
Woodruff TK, Meunier H, Jones PB, Hsueh AJW, Mayo KE 1987 Rat
inhibin: molecular cloning of
- and ß-subunit complementary
deoxyribonucleic acids and expression in the ovary. Mol Endocrinol 1:561568[Abstract]
-
Chan Y-L, Lin A, McNally J, Pelleg D, Meyuhas O, Wool I 1987 The primary structure of ribosomal protein L19. J Biol Chem 262:11111115[Abstract/Free Full Text]
-
Meinkoth J, Wahl G 1984 Hybridization of nucleic acids
immobilized on solid supports. Anal Biochem 138:267284[Medline]
-
Tohgo A, Takasawa S, Munakata H, Yonekura H, Hayashi N,
Okamoto H 1994 Structural determination and characterization of a 40
kDa protein isolated from rat 40 S ribosomal subunit. FEBS Lett 340:133138[CrossRef][Medline]
-
Campbell MJ 1995 Lipofection reagents prepared by a simple
ethanol injection technique. Biotechniques 18:10271032[Medline]
-
Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M,
Northrop JP, Ringold JP, Danielsen M 1987 Lipofection: a highly
efficient, lipid-mediated DNA transfection procedure. Proc Natl
Acad Sci USA 84:74137417[Abstract]
-
de Wet JR, Wood KV, Deluca M, Helinskin DR, Subramani S 1987 Firefly luciferase gene: structure and expression in mammalian cells.
Mol Cell Biol 7:725737[Medline]